Using gene expression profiling to identify a prognostic molecular spectrum in gliomas
Open Access
- 1 January 2009
- journal article
- Published by Wiley in Cancer Science
- Vol. 100 (1) , 165-172
Abstract
Histopathological classification of gliomas is often clinically inadequate due to the diversity of tumors that fall within the same class. The goal of the present study was to identify prognostic molecular features in diffusely infiltrating gliomas using gene expression profiling. We selected 3456 genes expressed in gliomas, including 3012 genes found in a gliomal expressed sequence tag collection. The expression levels of these genes in 152 gliomas (100 glioblastomas, 21 anaplastic astrocytomas, 19 diffuse astrocytomas, and 12 anaplastic oligodendrogliomas) were measured using adapter‐tagged competitive polymerase chain reaction, a high‐throughput reverse transcription–polymerase chain reaction technique. We applied unsupervised and supervised principal component analyses to elucidate the prognostic molecular features of the gliomas. The gene expression data matrix was significantly correlated with the histological grades, oligo‐astro histology, and prognosis. Using 110 gliomas, we constructed a prediction model based on the expression profile of 58 genes, resulting in a scheme that reliably classified the glioblastomas into two distinct prognostic subgroups. The model was then tested with another 42 tissues. Multivariate Cox analysis of the glioblastoma patients using other clinical prognostic factors, including age and the extent of surgical resection, indicated that the gene expression profile was a strong and independent prognostic parameter. The gene expression profiling identified clinically informative prognostic molecular features in astrocytic and oligodendroglial tumors that were more reliable than the traditional histological classification scheme. (Cancer Sci 2009; 100: 165–172)Keywords
This publication has 33 references indexed in Scilit:
- Gene Expression-Based Molecular Diagnostic System for Malignant Gliomas Is Superior to Histological DiagnosisClinical Cancer Research, 2007
- Phase II study of nimustine, carboplatin, vincristine, and interferon-β with radiotherapy for glioblastoma multiforme: experience of the Kyoto Neuro-Oncology GroupJournal of Neurosurgery, 2006
- Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesisCancer Cell, 2006
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaNew England Journal of Medicine, 2005
- Prediction of Docetaxel Response in Human Breast Cancer by Gene Expression ProfilingJournal of Clinical Oncology, 2005
- A Bayesian missing value estimation method for gene expression profile dataBioinformatics, 2003
- Glioma ClassificationThe American Journal of Pathology, 2001
- Gene expression in mouse cerebellum during its developmentGene, 2000
- Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic OligodendrogliomasJNCI: Journal of the National Cancer Institute, 1998
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences of the United States of America, 1996